3D-ASC-Exos as a novel drug carrier for glioma treatment
3D-ASC-Exos can be used as a novel drug carrier for glioma treatment. The development of 3D-ASC-Exos as a drug carrier not only provides a better strategy for tumor treatment, but also demonstrates the broad potential of exosomes in targeted tumor therapy.
Authors
- Xinrui Yan
- Rui Han (ORCID: https://orcid.org/0000-0001-8856-3681)
- Rui Du (ORCID: https://orcid.org/0000-0002-9703-3575)
- Xintong Han (ORCID: https://orcid.org/0000-0001-7369-0506)
- Boyin Jia (ORCID: https://orcid.org/0000-0002-7901-6675)
- Nai-Chao Diao
- Yanwen Zhang (ORCID: https://orcid.org/0000-0003-1833-3885)
- Chang Liu (ORCID: https://orcid.org/0000-0001-5219-1089)
- Xin Li (ORCID: https://orcid.org/0000-0003-0958-1078)
- Yaxin Li (ORCID: https://orcid.org/0000-0002-2981-1996)
- Jianming Li (ORCID: https://orcid.org/0000-0002-2862-9922)
- Wei Liu (ORCID: https://orcid.org/0000-0002-6665-220X)
Institutions
- Yanbian University (CN)
- Jilin Agricultural University (CN)
Publication Details
- Journal
- Frontiers in Cell and Developmental Biology
- Published
- 2025-09-25
- DOI
- https://doi.org/10.3389/fcell.2025.1677555
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00